1. © Datamonitor the home of Business Intelligence intuitive deliveryexpert analysisquality data © Datamonitor

2. PharmaVitae: Takeda Pharmaceutical Co., Ltd HC00068-035 Slidepack 11/11 quality dataexpert analysisintuitive delivery the home of Business Intelligence

3. Takeda prescription pharmaceutical performance, sales ($m) and growth rate (%), 2004–16

4. Takeda financial performance ($m), 2004–16

5. Takeda’s key product sales ($m), 2004–16

6. Takeda’s key product growth drivers and resistors ($m), 2004–10

7. Takeda’s key product growth drivers and resistors ($m), 2010–16

8. Takeda prescription pharmaceutical sales by therapy area ($m), 2004–16

9. Takeda prescription pharmaceutical sales by geographic region ($m), 2004–16

10. Takeda launch, core and expiry configuration, sales ($m), 2010–16

11. Takeda prescription pharmaceutical sales by molecule type ($m), 2004–16

12. Takeda prescription pharmaceutical sales by source of product ($m), 2004–16

13. Takeda operating revenue/cost analysis ($m), 2004–16

14. Blopress sales by geography and analyst consensus ($m), 2004–16

15. Lupron Depot sales by geography and analyst consensus ($m), 2004–16

16. Actos sales by geography and analyst consensus ($m), 2004–16

17. Liovel sales by geography and analyst consensus ($m), 2004–16

18. Enbrel sales by geography and analyst consensus ($m), 2004–16

19. Takepron sales by geography and analyst consensus ($m), 2004–16

20. Nesina sales by geography and analyst consensus ($m), 2004–16

21. Velcade sales by geography and analyst consensus ($m), 2004–16

22. © Datamonitor the home of Business Intelligence intuitive deliveryexpert analysisquality data © Datamonitor